Market Place
Sourcing Support
All News #Library
Biotech
Poseida Therapeutics Highlights Positive Interim Phase 1 Results
09 Dec 2024 //
PR NEWSWIRE
Roche agreement to acquire Poseida Therapeutics
26 Nov 2024 //
GLOBENEWSWIRE
Poseida Therapeutics Reports Q3 2024 Financials & Updates
07 Nov 2024 //
PR NEWSWIRE
Poseida Present Data Supporting Gene Edit For Hereditary Angioedema
24 Oct 2024 //
PR NEWSWIRE
Poseida Reports Positive Phase 1 Results For P-BCMA-ALLO1
27 Sep 2024 //
PR NEWSWIRE
Poseida Therapeutics Presents Ph 1 Data on CAR-T P-BCMA-ALLO1 at Myeloma Meeting
05 Sep 2024 //
PR NEWSWIRE
Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
02 May 2024 //
PR NEWSWIRE
Poseida Presents New Phase 1 Data at AACR 2024
08 Apr 2024 //
PR NEWSWIRE
Poseida Therapeutics to Present at H.C. Wainwright 2nd Cell Therapy Conference
19 Mar 2024 //
PR NEWSWIRE
Poseida Announces FDA Clearance of Investigational NDA for P-CD19CD20-ALLO1
05 Jul 2023 //
PR NEWSWIRE
Poseida Presents Preclinical Data Across its Gene Therapy Programs
18 May 2023 //
PR NEWSWIRE
Poseida Therapeutics Provides Updates and Financial Results for the 1Q of 2023
09 May 2023 //
PR NEWSWIRE
Poseida Therapeutics Names Kristin Yarema President, Cell Therapy
11 Apr 2023 //
CONTRACT PHARMA
Poseida Provides Financial Results for the Fourth Quarter and Full Year 2022
09 Mar 2023 //
PR NEWSWIRE
Poseida Appoints Five New Members to Its Gene Therapy Scientific Advisory Board
01 Mar 2023 //
PR NEWSWIRE
Poseida to Present at H.C. Wainwright Cell Therapy Virtual Conference
14 Feb 2023 //
PR NEWSWIRE
Poseida Therapeutics to Host Third Annual Virtual R&D Day on February 22, 2023
08 Feb 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.